Cardiovascular disease test kit BMAPBP0110

for apolipoproteinsCOVID-19whole blood

This product facilitates the quantitative detection of ApoB in human whole blood or fingerstick blood and must be utilized in conjunction with an iPrtotin reader. In clinical settings, the ApoB assessment holds significance as a diagnostic aid in determining the risk of cardiovascular disease. It serves as an indicator for evaluating the risk of coronary heart disease. Recent research findings indicate a negative correlation between Apo A1 and coronary heart disease, while ApoB exhibits a positive correlation. Patients with coronary heart disease typically manifest lower levels of Apo A1 and elevated levels of ApoB. Screening and diagnosing through this method offer a valuable opportunity to identify individuals at high risk, prompting timely intervention to eliminate or manage other risk factors associated with cardiovascular diseases. Product Performance Properties (1) Linearity range ApoB concentration 8.0 2 02.2 mg/dL, conducted in accordance with CLSI EP6 A guidelines (2) Accuracy The limit of detection (LoB) for the blank is 5.47 mg/dL, while the limit of detection (LoD) is 8.01mg/dL, conducted in accordance with CLSI EP17-A guidelines, 60 replicate tests were performed on low concentration samples. (3) Precision Intra-study Conducted according to CLSI EP5 A2 guidelines, 3 whole blood samples were tested 20 times in the same assay. (Please contact manufacturer for more information) Storage conditions: Ambient temperature: 2~24 ℃; relative humidity: < 85% Approved - CE, FDA, TFDA listing